SEC Filing Summary: National Health Investors Inc. (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors Inc. on August 10, 2026. The filing serves as a Regulation FD disclosure to furnish Supplemental Information for the quarter ended June 30, 2026. The company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Supplemental Information (Exhibit 99.1) and the company's website, which are not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that supplemental data for the quarter ended June 30, 2026, is being made available to the public.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, contingencies, or details on unusual items. The document strictly references the availability of supplemental information elsewhere.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended June 30, 2026, by reviewing Exhibit 99.1 or the company website (www.nhireit.com).
- Confirm the details of the supplemental information referenced in Item 7.01 to ensure no material data was omitted from the filing text.
- Check for any press releases or investor presentations issued concurrently with this 8-K for additional context on the quarter's performance.